TrialJournal of thrombosis and thrombolysis2019

Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patients.

Xiaoli Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.